MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, ZVSA has $347,901 in assets. $12,734,687 in debts.

Balance Sheets Overview

Current Ratio
2.73%
Quick Ratio
2.73%
Debt to Asset Ratio
3660.43%
Unit: Dollar
Assets Breakdown
    • Prepaid expenses and other curre...
    • Cash
    • Vendor deposits
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in-capital
    • Accounts payable
    • Others

Balance Sheets
2025-12-31
Cash
101,778
Prepaid expenses and other current assets
231,639
Vendor deposits
14,484
Total current assets
347,901
Total assets
347,901
Accounts payable
10,123,391
Accrued expenses and other current liabilities
2,611,296
Total current liabilities
12,734,687
Total liabilities
12,734,687
Preferred stock
1
Common stock
809
Additional paid-in-capital
125,204,509
Accumulated deficit
-137,584,937
Treasury stock, at cost, 7 shares at december 31, 2025 and 2024
7,168
Total stockholders (deficit) equity
-12,386,786
Total liabilities and stockholders (deficit) equity
347,901
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother current assets$231,639 Cash$101,778 Vendor deposits$14,484 Total current assets$347,901 Total assets$347,901 Accumulated deficit-$137,584,937 Treasury stock, at cost, 7shares at december 31,...$7,168 Total liabilities andstockholders (deficit)...$347,901 Total stockholders(deficit) equity-$12,386,786 Additionalpaid-in-capital$125,204,509 Common stock$809 Preferred stock$1 Total liabilities$12,734,687 Total currentliabilities$12,734,687 Accounts payable$10,123,391 Accrued expenses andother current...$2,611,296

ZyVersa Therapeutics, Inc. (ZVSA)

ZyVersa Therapeutics, Inc. (ZVSA)